Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

Market Cap	4.01B
Revenue (ttm)	2.08B
Net Income (ttm)	443.72M
Shares Out	14.93M
EPS (ttm)	29.71
PE Ratio	9.03
Forward PE	n/a
Dividend	12.83 (4.70%)
Ex-Dividend Date	Dec 24, 2024

Volume	17,795
Average Volume	10,522
Open	281.96
Previous Close	281.96
Day's Range	271.50 - 285.00
52-Week Range	83.10 - 289.98
Beta	-0.09
RSI	78.66
Earnings Date	Oct 21, 2025

About EGX:CPCI

Kahira Pharmaceuticals & Chemical Industries Company engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt. The company is involved in the provision of chemicals, extracts, veterinary medicines, and pesticides; and packaging and distribution activities. It also exports its products to Iraq, Yemen, Sudan, Somalia, Jordan, Libya, Senegal, Zimbabwe, South Sudan, Mali, and Kenya. Kahira Pharmaceuticals & Chemical Industries Company was founded in 1962 and is headquartered in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 1,760
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: CPCI

Financial Performance

In 2025, EGX:CPCI's revenue was 2.08 billion, an increase of 52.80% compared to the previous year's 1.36 billion. Earnings were 443.72 million, an increase of 80.29%.